A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802.
Times cited: 57
Prognostic model for survival in patients with metastatic renal cell carcinoma: Results from the international kidney cancer working group.
Clinical Cancer Research.
Times cited: 92